Cerity Partners
VCYT icon

Cerity Partners’s Veracyte VCYT Stock Holding History

Cerity Partners’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.23M Buy
38,183
+29,106
+321% +$1.08M ﹤0.01% 1747
2025
Q4 		$382K Buy
+9,077
New +$366K ﹤0.01% 2265
2025
Q3 		– Sell
-23,424
Closed -$633K – 2878
2025
Q2 		$633K Buy
23,424
+11,205
+92% +$325K ﹤0.01% 1748
2025
Q1 		$362K Sell
12,219
-1,267
-9% -$48.3K ﹤0.01% 1926
2024
Q4 		$524K Buy
13,486
+814
+6% +$30.8K ﹤0.01% 1729
2024
Q3 		$431K Buy
+12,672
New +$356K ﹤0.01% 1855

Other funds holding VCYT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Cerity Partners's VCYT Position: Q1 2026 in Review

Cerity Partners increased its Veracyte (VCYT) stake by 321% in Q1 2026, buying an estimated $1.08M and bringing the position to 38,183 shares worth $1.23M. The position accounts for ﹤0.01% of the portfolio, ranked #1747.

Cerity Partners first reported a position in VCYT in Q3 2024 and has held it in 6 quarters since. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.

  • Cerity Partners held 38,183 shares of Veracyte worth $1.23M as of Q1 2026.
  • Cerity Partners bought 29,106 Veracyte shares in Q1 2026, an estimated $1.08M.
  • Veracyte made up ﹤0.01% of Cerity Partners's portfolio in Q1 2026, its #1747 holding.
  • Cerity Partners first reported a position in Veracyte in Q3 2024 and has held it in 6 quarters since.
  • 334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.

Based on Cerity Partners's 13F filing for Q1 2026, filed 15 May 2026.